| Literature DB >> 34899703 |
Gai Ge1, Haiqin Jiang1, Jingshu Xiong1, Wenyue Zhang1, Ying Shi1, Chenyue Tao2, Hongsheng Wang1,3,4.
Abstract
Mycobacteriosis, mostly resulting from Mycobacterium tuberculosis (MTb), nontuberculous mycobacteria (NTM), and Mycobacterium leprae (M. leprae), is the long-standing granulomatous disease that ravages several organs including skin, lung, and peripheral nerves, and it has a spectrum of clinical-pathologic features based on the interaction of bacilli and host immune response. Histiocytes in infectious granulomas mainly consist of infected and uninfected macrophages (Mφs), multinucleated giant cells (MGCs), epithelioid cells (ECs), and foam cells (FCs), which are commonly discovered in lesions in patients with mycobacteriosis. Granuloma Mφ polarization or reprogramming is the crucial appearance of the host immune response to pathogen aggression, which gets a command of endocellular microbe persistence. Herein, we recapitulate the current gaps and challenges during Mφ polarization and the different subpopulations of mycobacteriosis.Entities:
Keywords: epithelioid cells; foam cells; granuloma; macrophages; multinucleated giant cells; mycobacteriosis
Mesh:
Year: 2021 PMID: 34899703 PMCID: PMC8660122 DOI: 10.3389/fimmu.2021.752657
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561
Figure 1The granuloma and macrophages subsets. (A, B) Two frameworks of mycobacterial infection granuloma. (C–F) Reprogramming of macrophages and main markers of M1, M2, M3 and M4 Mϕ. Created with BioRender.com.
Main findings described in Mφs, MGCs, ECs, and FCs.
| Cell types | Stimulus | Main cyto/chemokines and enzymes | Functions/Immune responses | References |
|---|---|---|---|---|
| M1 Mφ | IFN-γ/STAT1, p53, ESAT6 | iNOS, IFN-γ, TNF-α, CD86, IL-6, and HMGN2 | Microbicidal activity and proinflammatory cytokine production | ( |
| M2 Mφ | IL-4 plus IL-13/STAT6, ESAT6, type I IFN | Arg-1, IL-10, TGF-β, fibroblast growth factor-β, CD206, CD163 | Immunosuppressive response and tissue repairment | ( |
| M3 Mφ | RF-M1/2 | IL-10, TNF-α, CD11b, F4/80, Ly6Chi CX3CR1hi | Undetailed | ( |
| M4 Mφ | CXCL4 | CD68, MRP8, MMP7 | Weak phagocytosis, favoring bacillus regeneration | ( |
| MGC | IL-4 or IL-13, GM-CSF plus IL-4, IFN-γ plus IL-3, E-cadherin, IL-15 | iNOS, EMMMs, PD-L1 | Inhibiting mycobacterial cell-to-cell spread or tissue destruction and mycobacterial latency | ( |
| EC | ESAT6 plus TLR2 | CD68+ CD163-, CD68+ CD163+ | Strongly phagocytic and microbicidal or nonphagocytic cells with secretory functions | ( |
| FC | PPAR, IL-10 | TNF-a, IL-1β, IL-6 | Favoring inherited response or pathogen persistence, Less-bactericidal, Less-phagocytic | ( |
Arg-1, arginase-1; CXCL, C-X-C motif ligand; ECs, epithelioid cells; EMMMs, extracellular matrix-degrading epithelioid macrophage marker molecules; ESAT6, early secreted antigenic target of 6-kDa; FCs, foamy cells; HMGN2, high-mobility group N2; IFN-γ, interferon-gamma; IL, interleukin; iNOS, inducible nitric oxide synthase; IRF, Interferon regulatory factors; Mφs, macrophages; MGCs, multinucleated giant cells; MMP, matrix metallo proteinase; MRP8, myeloid-related protein 8; PD-L1, programmed cell death ligand-1; RF-M1, reprogramming factor M1; STAT, signal transducer and activator of transcription; TGF-β, transforming growth factor beta; TNF-α, tumor necrosis factor-alpha.